Scar formation is a potentially detrimental process of tissue restoration in adults, affecting organ form and function. During fetal development, cutaneous wounds heal without inflammation or scarring at early stages of development, but begin to heal with significant inflammation and scarring as the skin becomes more mature. One possible cell type that could regulate the change from scarless to fibrotic healing is the mast cell. We show here that dermal mast cells in scarless wounds generated at embryonic day 15 (E15) are fewer in number, less mature and do not degranulate in response to wounding as effectively as mast cells of fibrotic wounds made at embryonic day 18 (E18). Differences were also observed between cultured mast cells from E15 and E18 skin with regard to degranulation and preformed cytokine levels. Injection of mast cell lysates into E15 wounds disrupted scarless healing, suggesting that mast cells interfere with scarless repair. Finally, wounds produced at E18, which normally heal with a scar, healed with significantly smaller scars in mast cell-deficient KitW/W-v mice compared to Kit+/+ littermates. Together, these data suggest that mast cells enhance scar formation, and that these cells may mediate the transition from scarless to fibrotic healing during fetal development.
Scar formation is a potentially detrimental process of tissue restoration in adults, affecting organ form and function. During fetal development there is a stage at which skin heals without inflammation or scarring. We use a murine model of fetal wound healing in which embryonic day 15 (E15) wounds heal scarlessly and without inflammation. In contrast, fetal wounds generated on embryonic day 18 (E18) heal with inflammation and scarring. One possible mediator of this change in wound healing is the mast cell. Mast cells are resident innate immune cells involved in the initiation of inflammation. We have found that the skin of E15 fetuses has fewer total mast cells than E18 skin. Furthermore, the mast cells of E15 skin are less mature and do not degranulate in response to wounding as effectively as mast cells of E18 skin. To determine if these differences in mast cells affect wound healing we utilized mast cell‐deficient mice (KitW/Wv mice) in our model. Inflammation and scar formation in wounded E18 skin was assessed. A two fold decrease in scar width was observed in the mast cell‐deficient mice compared to wild‐type littermates. These data suggest that mast cells may play an enhancing role in scar formation. More studies are needed to determine the specific mediators and mechanisms by which mast cells promote scarring. Supported in part by the Ohio State University Department of Pathology and NIH Grant CA127109.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.